Eli Lilly: A Safe Harbor Amid Market Volatility
Eli Lilly's stock is undervalued; defensive healthcare stocks shine amid uncertainty, and Eli Lilly drives growth. Click here ...
FDA voices ‘concerns’ with unapproved GLP-1 drugs used for weight loss
FDA is aware that some patients and health care professionals may look to unapproved versions of GLP-1 – glucagon-like peptide-1 receptor agonists – drugs, including semaglutide and tirzepatide, as an ...
Oppenheimer biotech analyst holds an analyst/industry conference call
Biotech Analyst Biegler, along with Dr Krishnamurthy, Associate Professor of Medicine & Co-Director of Breast Cancer Program at the ...
Why Organon Is A Top Pick For Income Investors
Organon pleasantly surprised me with its financial results for Q4 2024. Read why I believe OGN is an attractive stock for ...
Eli Lilly & Co. stock outperforms competitors on strong trading day
Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...